Clinical Trial Update: Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOT [Phase 1, Phase 2]

View source ↗

Summary

This update reports the PILOT trial evaluating APSV, a vaccinia virus vaccine, in vaccinia-naive subjects across Phase 1 and Phase 2. The study status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Vaccinia Virus Vaccine (APSV) (Vaccinia virus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Smallpox | Phase 1, Phase 2 | Status: COMPLETED